These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28374941)

  • 1. Characterizing Physical Properties of Superparamagnetic Nanoparticles in Liquid Phase Using Brownian Relaxation.
    Wu K; Schliep K; Zhang X; Liu J; Ma B; Wang JP
    Small; 2017 Jun; 13(22):. PubMed ID: 28374941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single and Dual Surfactants Coated Hydrophilic Superparamagnetic Iron Oxide Nanoparticles for Magnetic Fluid Hyperthermia Applications.
    Sudame A; Kandasamy G; Maity D
    J Nanosci Nanotechnol; 2019 Jul; 19(7):3991-3999. PubMed ID: 30764960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteinizing hormone-releasing hormone targeted superparamagnetic gold nanoshells for a combination therapy of hyperthermia and controlled drug delivery.
    Mohammad F; Al-Lohedan HA
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():692-700. PubMed ID: 28482580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation and characterization of citric acid-modified superparamagnetic iron oxide nanoparticles].
    Wang H; Qin XY; Li ZY; Zheng ZZ; Fan TY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):340-346. PubMed ID: 29643537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect.
    Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T
    ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
    Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioma-targeted superparamagnetic iron oxide nanoparticles as drug-carrying vehicles for theranostic effects.
    Xu HL; Mao KL; Huang YP; Yang JJ; Xu J; Chen PP; Fan ZL; Zou S; Gao ZZ; Yin JY; Xiao J; Lu CT; Zhang BL; Zhao YZ
    Nanoscale; 2016 Aug; 8(29):14222-36. PubMed ID: 27396404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Cubic Mesophases Combined with Superparamagnetic Iron Oxide Nanoparticles: A Hybrid Multifunctional Platform with Tunable Magnetic Properties for Nanomedical Applications.
    Caselli L; Mendozza M; Muzzi B; Toti A; Montis C; Mello T; Di Cesare Mannelli L; Ghelardini C; Sangregorio C; Berti D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the thermotropic and magnetotropic phase behavior of lipid liquid crystals containing magnetic nanoparticles.
    Mendozza M; Montis C; Caselli L; Wolf M; Baglioni P; Berti D
    Nanoscale; 2018 Feb; 10(7):3480-3488. PubMed ID: 29404545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of medium viscosity and intracellular environment on the magnetization of superparamagnetic nanoparticles in silk fibroin solutions and 3T3 mouse fibroblast cell cultures.
    Urbano-Bojorge AL; Casanova-Carvajal O; Félix-González N; Fernández L; Madurga R; Sánchez-Cabezas S; Aznar E; Ramos M; Serrano-Olmedo JJ
    Nanotechnology; 2018 Sep; 29(38):385705. PubMed ID: 29947336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superparamagnetic Iron Oxide Nanoparticles Modified with Silica Layers as Potential Agents for Lung Cancer Treatment.
    Reczyńska K; Marszałek M; Zarzycki A; Reczyński W; Kornaus K; Pamuła E; Chrzanowski W
    Nanomaterials (Basel); 2020 May; 10(6):. PubMed ID: 32486431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor-targeted cells and gliomas.
    Mu K; Zhang S; Ai T; Jiang J; Yao Y; Jiang L; Zhou Q; Xiang H; Zhu Y; Yang X; Zhu W
    Mol Imaging; 2015; 14():. PubMed ID: 26044549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ion-Mobility-Based Quantification of Surface-Coating-Dependent Binding of Serum Albumin to Superparamagnetic Iron Oxide Nanoparticles.
    Jeon S; Oberreit DR; Van Schooneveld G; Gao Z; Bischof JC; Haynes CL; Hogan CJ
    ACS Appl Mater Interfaces; 2016 Sep; 8(37):24482-90. PubMed ID: 27580340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superparamagnetic Iron Oxide Nanoparticles-Current and Prospective Medical Applications.
    Dulińska-Litewka J; Łazarczyk A; Hałubiec P; Szafrański O; Karnas K; Karewicz A
    Materials (Basel); 2019 Feb; 12(4):. PubMed ID: 30791358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy.
    Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY
    Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering magnetic-molecular sequential targeting nanoparticles for anti-cancer therapy.
    Zhang Q; Zhu J; Song L; Zhang J; Kong D; Zhao Y; Wang Z
    J Mater Chem B; 2013 Dec; 1(46):6402-6410. PubMed ID: 32261338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis conditions and characterization of superparamagnetic iron oxide nanoparticles with oleic acid stabilizer.
    Wulandari AD; Sutriyo S; Rahmasari R
    J Adv Pharm Technol Res; 2022; 13(2):89-94. PubMed ID: 35464655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-precipitation of DEAE-dextran coated SPIONs: how synthesis conditions affect particle properties, stem cell labelling and MR contrast.
    Barrow M; Taylor A; García Carrión J; Mandal P; Park BK; Poptani H; Murray P; Rosseinsky MJ; Adams DJ
    Contrast Media Mol Imaging; 2016 Sep; 11(5):362-370. PubMed ID: 27358113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties.
    He X; Wu X; Cai X; Lin S; Xie M; Zhu X; Yan D
    Langmuir; 2012 Aug; 28(32):11929-38. PubMed ID: 22799877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.